The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
£10,000,000,000
Before we sit down to discuss.
I got the zeros right, I've counted them.
A takeover would be meaningless, if we were struggling like Sierra then makes sense but we are not.
Refining anyone of our molecules through Phase 1 would net us a massive amount for that molecule ONLY.Providing enough funds to see the others through P1.
We have the money to get 1801 through P1, it's value alone I reckon would be far more than a T/O value for the whole company now.
T/O sound great but where we are it would be a disappointment.
Just my thoughts
What WIP said at 13:09
Miserable bunch
https://www.stocktitan.net/news/SRRA/gsk-reaches-agreement-to-acquire-late-stage-biopharmaceutical-o218aki9j4fy.html#:~:text=LONDON%20GlaxoSmithKline%20plc%20(LSE%2FNYSE,treatment%20of%20rare%20forms%20of
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn
So true, it's a bank holiday weekend.
In other words, if the daily rise continues till say Friday close and if no speeding ticket or news are issued, then gird your loins.
It could be anything and it might just be spectacular (I hope)
Sierra 737, secret patent, covid linked, license, deal idk
Brace yourselves folks
Long may your mutterings continue....
Batonrouge,
My memory ain't the best but I can't remember anything ever leaking from Sareum. Way too tight. And that's a good thing might I add.
Just enjoying the rise, overdue, and well deserved by all holders.
Gla
Autonomous,
we just had a Q&A not too long ago at the EGM
Highly anticipated - CTA for SDC-1801 Q2
Phase 1 trial to start, fully funded
Highly expected - CTA for 1802 (some have said this, am driven to believe they have a good point)
AGILE funding plus Covid plans
737 Sierra (drum beats)
Secret Patent
Good chance - Institutions to take a seat
More HNWIs and Revelation of who they are (i wish)
Offer, Buyout, Licence, T/O
People are mostly frustrated at seeing a loss when they log into their accounts. Sar is not a get rich quick, tamper down expectations but when the DEAL lands, this will fly. Those who've been here a long time know the deal. Tim in an interview for a few minutes lol. Waste of time. He won't give anything away. Watch him mumble his way through it. Lets wait for the good news.
Have a good weekend folks
Webb-y, deep breaths.
Follow what Andonthisday posted, search out clinical trials of every phase WORLD WIDE. Send emails make calls. (I don't doubt you're already doing this)
Post your story on Twitter and hashtag it, pin it.
Be strong and steady my friend.
Leggster, I tend to think of us lot as the Early Birds.
Buy cheap sell high. Pre clinical is the cheapest big pharma can get their greasy hands on one of our molecules.
Post P1 with solid and promising results, it will be a bidding war like never before. I can wait.
As Pi's we benefit from every compound we have going forward. Potential from all fronts. So with every step forward, sp appreciates 737, Agile, you name it. And on top of all of that, a race by big pharma to acquire 1801. Gonna be worth it unless one makes an early move any day now.
'We gamble that a big pharma will be willing to pay a fraction of the potential market size based on preclinical and early trial data. That is the SAREUM BUSINESS MODEL and sooner or later, the data will be impossible to ignore.'
This has been going over my mind for some days now and rightly said Potnak, it's going to happen.
The plan has never been to go P3, but to discover, refine, get some good trial results and SALE. Of compound not company, unless they want the whole thing.
Which lightly convinces me that talks have begun but Tim and co are likely asking for more and being as ****y as possible and since the HNWIs came onboard, we are strong on that poker table. The HNWIs came on board to cover P1, it's going to happen. Great results from that and we all know what that can do to the sp. Look at the figures Sareum once posted.
It's going to happen. SDC-1801.
It's 20 years
I would have to agree, maybe same person multiple accounts or a paid group of people.
Saw two posts same minute from two different accounts earlier today, identical worthless post.
Filtered a couple and my chat is green, refreshing
'SDC-1801’s clinical transition progressing to plan
Completion of final pre-clinical toxicology and safety studies for SDC-1801 in Q421 marks a key milestone for the company. While we are encouraged by this, final results from the study (data analysis underway, with results expected by the end of March 2022) would be instrumental in shaping Sareum’s plans for a CTA filing, particularly in light of ongoing toxicity concerns around the janus kinase (JAK) class of assets. Management has indicated that preliminary data from the studies appear PROMISING (meeting the objective of identifying organs/tissues susceptible to high-dose toxicity and determine the appropriate first-in-human dose range) and support SDC-1801’s progression to the clinic. Sareum expects to initiate Phase Ia clinical trials in H222 pending successful CTA filing (with the Medicines and Healthcare products Regulatory Agency) and approval in mid-2022. While the study design is still being finalised (with guidance from external consultants), Sareum has disclosed the trial will investigate the safety of ascending doses of SDC-1801 in healthy volunteers, before the selection of an initial indication for further clinical studies in patients. In addition to safety, the first trial would aim to assess initial efficacy signals by analysing SDC-1801’s effect on certain predictive biomarkers of autoimmune disease. Progress on the manufacturing front remain on track with the SDC-1801 API and oral capsule formulation under GMP conditions expected to be available by the time the trial starts in H222.
Just a reminder
Maidit308 cheers
'Looking good for the imminent and rapid progression of SRA737'
Let's go Sareum
Giddy up
Great find Citizen79.
Ndr50 those were my thoughts also, but am certainly looking forward to the next few weeks.
People are just letting off steam.
https://www.abc27.com/news/health/coronavirus/china-locks-down-city-of-9-million-amid-new-spike-in-covid-cases/?utm_campaign=socialflow&utm_medium=referral&utm_source=t.co
Brace yourselves for potentially more lock-downs
Matt,
Consolidation imo is about placing with institutions. Of course Agile route is still available. 2p, consolidation or not, we would still be at this price. I have never liked consolidation but it has happened. Let's get over it and wait for the tox and the news thereafter. Offer might soon be on the table for Sierra, who knows. A lot stands to happen with Sar.
Have faith and be kind to one another.
Cobaltblue, you speak as if prices only go up.
Perhaps, they bought in for the science irrespective of share price movements, they are not here for small gains and bought for deals. Their advisors did not tell them, it will rise as soon as you buy trust me.
Prices go up and down, don't let the pain of the drop easily control your emotions. What you've said makes no sense.
Sareum has gone up and down for over a decade. Anyone can spot that on a graph in a minute. We are all here for the deal so are they.